首页 | 本学科首页   官方微博 | 高级检索  
     

骶骨脊索瘤的临床特点及综合治疗
引用本文:曹东,肖建如,马俊明,杨兴海,冯大鹏. 骶骨脊索瘤的临床特点及综合治疗[J]. 脊柱外科杂志, 2007, 5(6): 350-353
作者姓名:曹东  肖建如  马俊明  杨兴海  冯大鹏
作者单位:第二军医大学附属长征医院骨科,上海,200003;第二军医大学附属长征医院骨科,上海,200003;第二军医大学附属长征医院骨科,上海,200003;第二军医大学附属长征医院骨科,上海,200003;第二军医大学附属长征医院骨科,上海,200003
摘    要:目的介绍骶骨脊索瘤的临床特点并对其综合治疗的疗效和相关问题进行分析。方法对1999年12月~2006年12月收治的行以手术切除为主的综合治疗的40例骶骨脊索瘤病例进行回顾性分析。结果本组病例无术中死亡,术后肿瘤局部复发13例,复发率为32.5%,其中3例复发2次;发生肺部转移2例,转移发生率为5%。术后5年内共5例死亡,患者经过综合治疗后的术后5年生存率达87.5%。结论以手术切除为主、辅以术中化疗、术后放疗的综合治疗方法,对降低骶骨脊索瘤的局部复发率、延长患者生存期、提高患者生活质量有重要作用,是治疗骶骨脊索瘤的有效方法。

关 键 词:骶骨  脊索瘤  肿瘤治疗方案
文章编号:1672-2957(2007)06-0350-04
收稿时间:2007-11-01
修稿时间:2007-11-01

Clinical characteristics and integrated treatments of the sacral chordoma
CAO Dong,XIAO Jianru,MA Junming,YANG Xinghai and FENG Dapeng. Clinical characteristics and integrated treatments of the sacral chordoma[J]. Journal of Spinal Surgery, 2007, 5(6): 350-353
Authors:CAO Dong  XIAO Jianru  MA Junming  YANG Xinghai  FENG Dapeng
Affiliation:Department of Orthopedics, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China;Department of Orthopedics, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China;Department of Orthopedics, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China;Department of Orthopedics, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China;Department of Orthopedics, Changzheng Hospital, the Second Military Medical University, Shanghai 200003, China
Abstract:Objective To summarize the clinical characteristics of the sacral chordomas and evaluate the integrated treatments and relevant issues. Methods Forty patients with sacral chordoma treated in our department from December 1999 to December 2006 were analyzed retrospectively. Results No intraoperative death occurred in this group. Thirteen cases had recurrence of the tumor, with a recurrence rate of 32.5%, and 2 cases had pulmonary metastasis, with a metastasis rate of 5%. Five patients died in the first 5 years after surgery, the overall 5-year survival rate is 87.5%. Conclusions The integrated treatments are an effective way to treat the sacral chordoma, which can lower the local recurrence rate, prolong the survival time, and improve patients' quality of life.
Keywords:Sacrum  Chordoma  Antineoplastic protocols
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《脊柱外科杂志》浏览原始摘要信息
点击此处可从《脊柱外科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号